Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China
- PMID: 37496692
- PMCID: PMC10368108
- DOI: 10.2147/IDR.S411283
Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China
Abstract
Background: Candida is one of the most important pathogens of hospital-acquired bloodstream infections. Its morbidity and mortality are still high, which is a serious global public problem.
Purpose: To investigate the strain distribution, drug susceptibility, clinical characteristics of patients, and risk factors affecting the prognosis of Candida bloodstream infection (BSI).
Materials and methods: We retrospectively collected the clinical data, infection-related indicators, prognosis, strain prevalence and drug susceptibility of 163 patients with Candida BSI in a teaching hospital from January 2012 to December 2022. Univariate and multivariate logistic regression were used to analyze the risk factors affecting the prognosis.
Results: In 163 cases of Candida BSI, Candida albicans accounted for 48.47%, and Candida non-albicans accounted for 51.53%. A total of 163 patients with Candida BSI were mainly distributed in intensive care unit (ICU) and emergency department, accounting for 40.49% and 14.72%, respectively. The resistance rate of Candida albicans to fluconazole, itraconazole and voriconazole was less than 10%, and the sensitivity rate of Candida tropicalis to fluconazole, itraconazole and voriconazole was less than 80%. The mortality rate of 163 patients with Candida BSI was 33.13%, with Candida non-albicans higher than that of Candida albicans (p = 0.04). Multivariate analysis showed that hemodialysis (OR = 0.199, 95% CI: 0.059-0.673, P = 0.009), arteriovenous catheters (OR = 0.344, 95% CI: 0.130-0.913, P = 0.032), elevated neutrophil count (OR = 0.409, 95% CI: 0.194-0.862, P = 0.019) and APACHE II score (OR = 0.848, 95% CI: 0.789~0.911, P < 0.001) were independent risk factors for death in patients with candidemia.
Conclusion: The blood flow infection rate of Candida non-albicans is increasing, and the mortality rate and resistance to antifungal drugs are higher than that of Candida albicans. Hemodialysis, arteriovenous catheters, elevated neutrophil count and APACHE II score were associated with death in patients with Candida BSI.
Keywords: Candida; bloodstream infection; clinical features; prognosis.
© 2023 Qiao et al.
Conflict of interest statement
The authors declare that there is no conflict of interest in this work.
Figures
Similar articles
-
Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China.Infect Drug Resist. 2024 Aug 7;17:3415-3423. doi: 10.2147/IDR.S471171. eCollection 2024. Infect Drug Resist. 2024. PMID: 39131515 Free PMC article.
-
Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.J Mycol Med. 2018 Mar;28(1):222-226. doi: 10.1016/j.mycmed.2017.05.001. Epub 2017 Dec 15. J Mycol Med. 2018. PMID: 29254811
-
Prevalence, Mortality, Antifungal Resistance, and Risk Factors of Candidemia Among Cancer Patients in a Single Center of Southern China: A 10-Year Retrospective Study.J Trop Med. 2025 Jun 5;2025:2653325. doi: 10.1155/jotm/2653325. eCollection 2025. J Trop Med. 2025. PMID: 40519336 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa.BMC Infect Dis. 2023 Feb 3;23(1):67. doi: 10.1186/s12879-023-08027-z. BMC Infect Dis. 2023. PMID: 36737689 Free PMC article.
Cited by
-
Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China.Infect Drug Resist. 2024 Aug 7;17:3415-3423. doi: 10.2147/IDR.S471171. eCollection 2024. Infect Drug Resist. 2024. PMID: 39131515 Free PMC article.
-
Epidemiology, clinical characteristics, and outcome in candidemia: a retrospective five-year analysis from two tertiary general hospitals.BMC Infect Dis. 2025 Apr 11;25(1):512. doi: 10.1186/s12879-025-10908-4. BMC Infect Dis. 2025. PMID: 40217142 Free PMC article.
-
Global Epidemiology of Invasive Infections by Uncommon Candida Species: A Systematic Review.J Fungi (Basel). 2024 Aug 7;10(8):558. doi: 10.3390/jof10080558. J Fungi (Basel). 2024. PMID: 39194884 Free PMC article. Review.
-
An AIE-active probe acts as novel tool for rapid and accurate quantitative antifungal susceptibility assessment.Front Microbiol. 2025 Mar 27;16:1566846. doi: 10.3389/fmicb.2025.1566846. eCollection 2025. Front Microbiol. 2025. PMID: 40212389 Free PMC article.
-
Epidemiological characteristics, antifungal susceptibility, and mortality factors of candidemia in adults at a tertiary teaching hospital in Zunyi, China (2016-2023).BMC Infect Dis. 2025 May 21;25(1):726. doi: 10.1186/s12879-025-11021-2. BMC Infect Dis. 2025. PMID: 40399823 Free PMC article.
References
LinkOut - more resources
Full Text Sources